Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$1.05
$2.08
$0.83
▼
$16.68
$1.08M0.896.25 million shs166,274 shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$0.34
$0.45
$0.27
▼
$5.12
$4.77M6.222.89 million shs1.69 million shs
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$6.32
$7.11
$5.02
▼
$95.60
$4.55M0.2344,789 shs15,296 shs
Zynex Inc. stock logo
ZYXI
Zynex
$0.13
$0.12
$0.12
▼
$2.82
$3.80M0.992.32 million shsN/A
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.00%-1.87%-27.59%-38.95%-80.70%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
0.00%+5.96%-18.16%-42.69%-91.65%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
0.00%+17.91%+13.26%-34.30%-86.38%
Zynex Inc. stock logo
ZYXI
Zynex
0.00%0.00%0.00%0.00%-91.78%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$1.05
$2.08
$0.83
▼
$16.68
$1.08M0.896.25 million shs166,274 shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$0.34
$0.45
$0.27
▼
$5.12
$4.77M6.222.89 million shs1.69 million shs
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$6.32
$7.11
$5.02
▼
$95.60
$4.55M0.2344,789 shs15,296 shs
Zynex Inc. stock logo
ZYXI
Zynex
$0.13
$0.12
$0.12
▼
$2.82
$3.80M0.992.32 million shsN/A
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.00%-1.87%-27.59%-38.95%-80.70%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
0.00%+5.96%-18.16%-42.69%-91.65%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
0.00%+17.91%+13.26%-34.30%-86.38%
Zynex Inc. stock logo
ZYXI
Zynex
0.00%0.00%0.00%0.00%-91.78%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
1.00
SellN/AN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.25
Hold$2.80715.61% Upside
Beyond Air, Inc. stock logo
XAIR
Beyond Air
2.33
Hold$200.003,064.56% Upside
Zynex Inc. stock logo
ZYXI
Zynex
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest BJDX, XAIR, VVOS, and ZYXI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/21/2026
Beyond Air, Inc. stock logo
XAIR
Beyond Air
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/17/2026
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/24/2026
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/4/2026
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
Ascendiant Capital Markets logo
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$3.00 ➝ $3.10
(Data available from 8/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/A$8.43 per shareN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$17.44M0.27N/AN/A($0.16) per share-2.15
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$7.68M0.59N/AN/A$9.41 per share0.67
Zynex Inc. stock logo
ZYXI
Zynex
$108.20M0.04$0.25 per share0.51$1.12 per share0.11
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$6.85M-$11.63N/AN/AN/AN/A-125.00%-99.79%8/19/2026 (Estimated)
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$21.17M-$2.14N/AN/AN/A-122.00%-2,325.64%-100.87%8/18/2026 (Estimated)
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$33.25M-$68.40N/AN/AN/A-435.71%-440.26%-98.50%N/A
Zynex Inc. stock logo
ZYXI
Zynex
$2.99M-$2.43N/A0.27N/A-68.35%-804.30%-36.67%N/A

Latest BJDX, XAIR, VVOS, and ZYXI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$0.41-$0.31+$0.10-$0.31$5.63 million$5.15 million
8/13/2026Q1 2027
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$10.80-$11.00-$0.20-$11.00$1.93 million$1.77 million
8/12/2026Q2 2026
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$3,520.00-$1.12+$3,518.88-$1.12N/AN/A
6/26/2026Q4 2026
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$11.3334-$15.40-$4.0666-$15.40$2.30 million$1.91 million
5/20/2026Q1 2026
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$0.45-$0.52-$0.07-$0.52$4.35 million$5.14 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/AN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/AN/AN/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
N/AN/AN/AN/AN/A
Zynex Inc. stock logo
ZYXI
Zynex
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/A
4.64
4.64
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/A
0.27
0.27
Beyond Air, Inc. stock logo
XAIR
Beyond Air
7.81
3.31
3.12
Zynex Inc. stock logo
ZYXI
Zynex
0.56
0.47
0.32

Institutional Ownership

CompanyInstitutional Ownership
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
18.47%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
26.35%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
31.50%
Zynex Inc. stock logo
ZYXI
Zynex
29.68%

Insider Ownership

CompanyInsider Ownership
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
6.10%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.10%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
9.99%
Zynex Inc. stock logo
ZYXI
Zynex
49.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
91.03 million972,000Not Optionable
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
16013.90 million13.60 millionOptionable
Beyond Air, Inc. stock logo
XAIR
Beyond Air
70720,000649,000Optionable
Zynex Inc. stock logo
ZYXI
Zynex
77030.39 million15.41 millionOptionable

Recent News About These Companies

Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm
July 21, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-zynex-inc-to-contact-law-firm-302831417.html
Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm
July 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/13/3326458/0/en/kuehn-law-encourages-investors-of-zynex-inc-to-contact-law-firm.html
ZYXIQ CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
April 21, 2026  |  newsfilecorp.comN
ZYXIQ INVESTOR ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Zynex, Inc.
April 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/16/3275368/0/en/ZYXIQ-INVESTOR-ALERT-Bernstein-Liebhard-LLP-Announces-A-Securities-Fraud-Class-Action-Lawsuit-Has-Been-Filed-Against-Zynex-Inc.html
ZYNEX LEAD PLAINTIFF DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Reminds Zynex, Inc Investors to Contact the Firm Before the April 21st Lead Plaintiff Deadline
April 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/13/3272950/0/en/ZYNEX-LEAD-PLAINTIFF-DEADLINE-APPROACHING-Bragar-Eagel-Squire-P-C-Reminds-Zynex-Inc-Investors-to-Contact-the-Firm-Before-the-April-21st-Lead-Plaintiff-Deadline.html
Levi & Korsinsky Notifies Zynex, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – ZYXIQ
April 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/13/3272847/3080/en/Levi-Korsinsky-Notifies-Zynex-Inc-Investors-of-a-Class-Action-Lawsuit-and-Upcoming-Deadline-ZYXIQ.html
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Zynex, Inc. (ZYXIQ)
April 10, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/11/3272087/10782/en/Gainey-McKenna-Egleston-Announces-A-Class-Action-Lawsuit-Has-Been-Filed-Against-Zynex-Inc-ZYXIQ.html
ZYXIQ Shareholder Alert: April 21, 2026 Lead Plaintiff Deadline in Zynex, Inc. Securities Class Action Lawsuit — The Gross Law Firm
April 10, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/10/3271885/0/en/ZYXIQ-Shareholder-Alert-April-21-2026-Lead-Plaintiff-Deadline-in-Zynex-Inc-Securities-Class-Action-Lawsuit-The-Gross-Law-Firm.html
ZYXIQ EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
April 9, 2026  |  newsfilecorp.comN
ZYXIQ INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Zynex Investors of Securities Class Action Deadline on April 21, 2026
April 3, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/zyxiq-investor-deadline-approaching-faruqi--faruqi-llp-reminds-zynex-investors-of-securities-class-action-deadline-on-april-21-2026-302733401.html
ZYXIQ UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
April 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/01/3266731/683/en/ZYXIQ-UPCOMING-DEADLINE-Faruqi-Faruqi-LLP-Reminds-Zynex-ZYXIQ-Investors-of-Securities-Class-Action-Deadline-on-April-21-2026.html
Zynex, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 21, 2026 to Discuss Your Rights - ZYXIQ
April 1, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/zynex-inc-sued-for-securities-law-violations---contact-levi--korsinsky-before-april-21-2026-to-discuss-your-rights--zyxiq-302731025.html
ZYXI SHAREHOLDER ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements
March 30, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/zyxi-shareholder-alert-hagens-berman-alerts-zynex-zyxi--zyxiq-investors-to-securities-class-action-following-bankruptcy-and-federal-fraud-settlements-302728935.html
ZYXIQ Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Zynex, Inc. Securities Lawsuit — The Gross Law Firm
March 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/27/3263906/0/en/ZYXIQ-Shareholder-Alert-Investors-With-Losses-May-Seek-to-Lead-the-Class-Action-in-Zynex-Inc-Securities-Lawsuit-The-Gross-Law-Firm.html
ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements
March 24, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/zyxi-shareholder-update-hagens-berman-alerts-zynex-zyxi--zyxiq-investors-to-securities-class-action-following-bankruptcy-and-federal-fraud-settlements-302723686.html
ZYXIQ CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
March 23, 2026  |  newsfilecorp.comN
ZYXI ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements
March 20, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/zyxi-alert-hagens-berman-alerts-zynex-zyxi--zyxiq-investors-to-securities-class-action-following-bankruptcy-and-federal-fraud-settlements-302720119.html
ZYXI SHAREHOLDER NOTICE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements
March 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/20/3259540/32716/en/ZYXI-SHAREHOLDER-NOTICE-Hagens-Berman-Alerts-Zynex-ZYXI-ZYXIQ-Investors-to-Securities-Class-Action-Following-Bankruptcy-and-Federal-Fraud-Settlements.html
Shareholders that lost money on Zynex, Inc. (ZYXIQ) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
March 18, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/shareholders-that-lost-money-on-zynex-inc-zyxiq-urged-to-join-class-action--contact-levi--korsinsky-to-learn-more-302716978.html
ZYXI INVESTOR ALERT: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements
March 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/17/3257798/32716/en/ZYXI-INVESTOR-ALERT-Hagens-Berman-Alerts-Zynex-ZYXI-ZYXIQ-Investors-to-Securities-Class-Action-Following-Bankruptcy-and-Federal-Fraud-Settlements.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bluejay Diagnostics stock logo

Bluejay Diagnostics NASDAQ:BJDX

$1.05 0.00 (0.00%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$1.04 -0.01 (-0.95%)
As of 08/14/2026 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Vivos Therapeutics stock logo

Vivos Therapeutics NASDAQ:VVOS

$0.34 0.00 (0.00%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$0.32 -0.03 (-7.66%)
As of 08/14/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

Beyond Air stock logo

Beyond Air NASDAQ:XAIR

$6.32 0.00 (0.00%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$6.32 0.00 (0.00%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Zynex stock logo

Zynex NASDAQ:ZYXI

$0.12 0.00 (0.00%)
As of 08/14/2026

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas